Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence

Código QR

Effectiveness of influenza vaccine in aging and older adults: comprehensive analysis of the evidence

Pierre-Olivier Lang1,2, Aline Mendes1, Jennifer Socquet1, Noémie Assir1, Sheila Govind2, Richard Aspinall21Department of Internal Medicine, Rehabilitation and Geriatrics, University Hospitals and Medical School of Geneva, Geneva, Switzerland; 2Translational Medicine Research Group, Cranfi...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Lang PO, Mendes A, Socquet J, Assir N, Govind S, Aspinall R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	influenza vaccine effectiveness influenza virus infection immunosenescence hemagglutinin activity inhibition innate immunity hemagglutinin inhibition older adults. Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/d07b59174a7f460092ccdb40d5e48171
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages
por: Kizzmekia S. Corbett, et al.
Publicado: (2019)

Isolation, sequencing and phylogenetic analysis of the hemagglutinin, neuraminidase and nucleoprotein genes of the Chilean equine influenza virus subtypes H7N7 and H3N8
por: Müller,Ilse, et al.
Publicado: (2005)

Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for <italic toggle="yes">In Vivo</italic> Protection in a Serum Transfer Mouse Challenge Model
por: Henning Jacobsen, et al.
Publicado: (2017)

Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies
por: Rie Nakajima, et al.
Publicado: (2018)

Human Influenza A Virus Hemagglutinin Glycan Evolution Follows a Temporal Pattern to a Glycan Limit
por: Meghan O. Altman, et al.
Publicado: (2019)

Stability of the Influenza Virus Hemagglutinin Protein Correlates with Evolutionary Dynamics
por: Eili Y. Klein, et al.
Publicado: (2018)

INFLUENZA VIRUS EPIDEMIOLOGICAL SITUATION IN THE SOUTH OF WESTERN SIBERIA IN 2011-2012
por: I. A. Sobolev, et al.
Publicado: (2012)

Influenza’s Newest Trick
por: Jeffery K. Taubenberger
Publicado: (2019)

PRODUCTION OF HYBRID RECOMBINANT PROTEIN Flu-Chim, CONTAINING INFLUENZA VIRUSES A AND B MAJOR EPITOPES
por: I. V. Dukhovlinov, et al.
Publicado: (2017)

Intranasal immunization with a recombinant protein based on the M2e peptide and second subunit of influenza A viral hemagglutinin fragment induces a cross-protective humoral and Tcell response in mice
por: M. A Shuklina, et al.
Publicado: (2020)

Granzyme B: A Double-Edged Sword in the Response to Influenza Infection in Vaccinated Older Adults
por: Chris P. Verschoor, et al.
Publicado: (2021)

Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains
por: Jiong Wang, et al.
Publicado: (2021)

Microneutralization reaction compared to hemagglutination inhibition assay to evaluate immunogenicity of influenza vaccines and influenza diagnostics
por: V. Z. Krivitskaya, et al.
Publicado: (2020)

The Hemagglutinin-Esterase Fusion Glycoprotein Is a Primary Determinant of the Exceptional Thermal and Acid Stability of Influenza D Virus
por: Jieshi Yu, et al.
Publicado: (2017)

Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
por: Madhusudan Rajendran, et al.
Publicado: (2017)

Molecular mechanisms of the influenza fusion peptide: insights from experimental and simulation studies
por: Diana Lousa, et al.
Publicado: (2021)

Pneumonia immunization in older adults: review of vaccine effectiveness and strategies
por: Assaad U, et al.
Publicado: (2012)

THE SPANISH INFLUENZA VIRUS: TREATS TO THE PORTRAIT AFTER 100 YEARS
por: E. P. Kharchenko
Publicado: (2018)

COMPARISON OF INFLUENZA A(H1N1)pdm09 GENOMES OBTAINED FROM DIFFERENT TYPES OF VIRUS-CONTAINING MATERIAL
por: A. V. Fadeev, et al.
Publicado: (2017)

Humoral immunity to influenza and severe influenza cases in Russia in 2018-2019
por: T. N. Ilyicheva, et al.
Publicado: (2020)

2019–2020 herd immunity to seasonal influenza viruses prior to epidemic season and rate of severe disease cases
por: T. N. Ilyicheva, et al.
Publicado: (2021)

Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
por: I. Losev, et al.
Publicado: (2019)

LOCAL ANTIBODY AND CELLULAR IMMUNE RESPONSES TO INFLUENZA INFECTION AND VACCINATION
por: G. D. Petukhova, et al.
Publicado: (2014)

Factors Associated with Attitudes towards Seasonal Influenza Vaccination in Poland: A Nationwide Cross-Sectional Survey in 2020
por: Piotr Samel-Kowalik, et al.
Publicado: (2021)

Influenza Vaccination Programs for Healthcare Personnel: Organizational Issues and Beyond
por: Helena C. Maltezou, et al.
Publicado: (2021)

NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?
por: Florian Krammer, et al.
Publicado: (2018)

Broadly Reactive Influenza Antibodies Are Not Limited by Germinal Center Competition with High-Affinity Antibodies
por: Rachael Keating, et al.
Publicado: (2020)

Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020–21 season
por: Chiara Gasparini, et al.
Publicado: (2021)

Patients’ Perception and Knowledge about Influenza and Pneumococcal Vaccination during the COVID-19 Pandemic: An Online Survey in Patients at Risk of Infections
por: Paul Loubet, et al.
Publicado: (2021)

Influenza: Profilaxis mediante la inmunización activa
por: FICA C.,ALBERTO
Publicado: (2001)

Enhancement of the Local CD8<sup>+</sup> T-Cellular Immune Response to <i>Mycobacterium tuberculosis</i> in BCG-Primed Mice after Intranasal Administration of Influenza Vector Vaccine Carrying TB10.4 and HspX Antigens
por: Kirill Vasilyev, et al.
Publicado: (2021)

INDUCTION OF LONG-TERM T AND B CELL MEMORY IMMUNITY TO INFLUENZA A VIRUS (H5N1) IN PERSONS VACCINATED WITH LIVE INFLUENZA A VACCINE (H5N2)
por: I. V. Losev, et al.
Publicado: (2017)

Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells
por: Li-Meng Yan, et al.
Publicado: (2020)

HETEROSUBTYPIC IMMUNE RESPONSE AND CROSS-PROTECTION AGAINST A HIGHLY PATHOGENIC A (H5N1) INFLUENZA VIRUS IN MICE IMMUNIZED WITH COLD-ADAPTED A/LENINGRAD/134/17/57 (H2N2) INFLUENZA VIRUS
por: A. R. Rekstin, et al.
Publicado: (2014)

Influenza vaccination and prognosis for patients with high cardiovascular risk
por: Olga A. Dmitrieva, et al.
Publicado: (2021)

Influenza B Lineages Have More in Common Than Meets the Eye. Trivalent Influenza Vaccines Trigger Heterotypic Antibodies Against Both Influenza B Viruses
por: Laura Sánchez-de Prada, et al.
Publicado: (2021)

Next-Generation Computationally Designed Influenza Hemagglutinin Vaccines Protect against H5Nx Virus Infections
por: Ivette A. Nuñez, et al.
Publicado: (2021)

A recombinant protein containing influenza viral conserved epitopes and superantigen induces broad-spectrum protection
por: Yansheng Li, et al.
Publicado: (2021)

IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
por: M. P. Kostinov, et al.
Publicado: (2017)

Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults
por: Philip Meade, et al.
Publicado: (2020)